STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 98 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $892,000 | -54.7% | 184,334 | -0.4% | 0.00% | -100.0% |
| Q4 2019 | $1,967,000 | +3.4% | 185,080 | +1.2% | 0.00% | 0.0% |
| Q3 2019 | $1,903,000 | -23.4% | 182,808 | +12.8% | 0.00% | 0.0% |
| Q2 2019 | $2,483,000 | +12.8% | 162,048 | -5.3% | 0.00% | 0.0% |
| Q1 2019 | $2,201,000 | +71.8% | 171,202 | +27.0% | 0.00% | – |
| Q4 2018 | $1,281,000 | -27.6% | 134,756 | +26.5% | 0.00% | – |
| Q3 2018 | $1,769,000 | +6.2% | 106,558 | +2.7% | 0.00% | – |
| Q2 2018 | $1,666,000 | -4.1% | 103,806 | -8.6% | 0.00% | – |
| Q1 2018 | $1,737,000 | +10.4% | 113,578 | +12.7% | 0.00% | – |
| Q4 2017 | $1,573,000 | +73.0% | 100,813 | +23.1% | 0.00% | – |
| Q3 2017 | $909,000 | +14.5% | 81,914 | -5.0% | 0.00% | – |
| Q2 2017 | $794,000 | +6.6% | 86,196 | -1.0% | 0.00% | – |
| Q1 2017 | $745,000 | +8.8% | 87,091 | +36.0% | 0.00% | – |
| Q4 2016 | $685,000 | +27.1% | 64,014 | +28.7% | 0.00% | – |
| Q3 2016 | $539,000 | +52.7% | 49,733 | -4.6% | 0.00% | – |
| Q2 2016 | $353,000 | +39.0% | 52,108 | -4.5% | 0.00% | – |
| Q1 2016 | $254,000 | -25.9% | 54,546 | +0.6% | 0.00% | – |
| Q4 2015 | $343,000 | -28.8% | 54,231 | -0.5% | 0.00% | – |
| Q3 2015 | $482,000 | -45.0% | 54,516 | -26.7% | 0.00% | – |
| Q2 2015 | $876,000 | -23.6% | 74,420 | -6.1% | 0.00% | – |
| Q1 2015 | $1,147,000 | +23.1% | 79,263 | +45.2% | 0.00% | – |
| Q4 2014 | $932,000 | +52.8% | 54,601 | +11.4% | 0.00% | – |
| Q3 2014 | $610,000 | -57.5% | 49,002 | -49.8% | 0.00% | – |
| Q2 2014 | $1,434,000 | +74.9% | 97,664 | +142.3% | 0.00% | – |
| Q1 2014 | $820,000 | +1.9% | 40,311 | -1.8% | 0.00% | – |
| Q4 2013 | $805,000 | -79.2% | 41,069 | -51.9% | 0.00% | -100.0% |
| Q3 2013 | $3,868,000 | +357.2% | 85,436 | +140.8% | 0.00% | – |
| Q2 2013 | $846,000 | – | 35,486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 1,471,518 | $23,618,000 | 8.40% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 492,930 | $7,862,000 | 3.02% |
| Consonance Capital Management LP | 2,747,198 | $44,093,000 | 2.84% |
| NEXTHERA CAPITAL LP | 559,517 | $8,980,000 | 1.39% |
| Eventide Asset Management | 1,086,400 | $17,437,000 | 0.72% |
| Virtus ETF Advisers LLC | 45,850 | $736,000 | 0.65% |
| KNOTT DAVID M | 90,000 | $1,445,000 | 0.54% |
| Polar Capital LLP | 1,912,605 | $30,697,000 | 0.18% |
| Artal Group S.A. | 400,000 | $6,420,000 | 0.14% |
| J. Goldman & Co LP | 100,000 | $1,605,000 | 0.08% |